Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Malignant Peripheral Nerve Sheath Tumors: early-phase trial registry
4 of 4 indexed Malignant Peripheral Nerve Sheath Tumors trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #4,115 of 28,707 conditions by registered trial count.
4 US clinical trials · 4 currently recruiting · #4,115 of 28,707 conditions by registered trial count
Malignant Peripheral Nerve Sheath Tumors: 4 US clinical trials tracked, 4 recruiting.
Malignant Peripheral Nerve Sheath Tumors is the subject of 4 registered US clinical trials on ClinicalTrials.gov, 4 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is David Miller, running 1 of these trials.
Enrollment posture brief
Registry condition malignant-peripheral-nerve-sheath-tumors
OPEN 4 | RECR 100% | LATE 0 | EARLY 2 | RANK #4115 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)
Malignant Peripheral Nerve Sheath Tumors lists 4 open slots (100% of 4 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Malignant Peripheral Nerve Sheath Tumors on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Malignant Peripheral Nerve Sheath Tumors is recruiting above its size-band peers.
4 of 4 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
4 total, page 1 of 1
Multi-Institutional Registry for Malignant Peripheral Nerve Sheath Tumors
Washington University School of Medicine
NCT03141021
Neurofibromatosis Type 1 Tumor Early Detection Study
David Miller
NCT06515860
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
Bristol-Myers Squibb
NCT05245500
A Study of Selinexor in People With Wilms Tumors and Other Solid Tumors
Memorial Sloan Kettering Cancer Center
NCT05985161
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Malignant Peripheral Nerve Sheath Tumors records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Malignant Peripheral Nerve Sheath Tumors trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Malignant Peripheral Nerve Sheath Tumors page
4 registered trials, 4 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 4 Malignant Peripheral Nerve Sheath Tumors trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- David Miller sponsors the most Malignant Peripheral Nerve Sheath Tumors trials on record, review their full trial history before evaluating a specific study. See David Miller's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Malignant Peripheral Nerve Sheath Tumors condition card totals 4 registered trials; most-linked intervention Liquid biopsy for MPNST development; top US site state Massachusetts. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.